Explain this page
Arphra AIPlain-English read on Vertex Pharmaceuticals Incorporated’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
$2,091.53
+380.03% vs spot
Recommendation
Strong Buy
15 of 16 methods
Method spread
4bull11bear
±5% threshold
Analyst PT consensus: $552.27 (+26.75%)
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.26% | -2.22% | +1.37% | -12.71% | -2.01% | -3.89% | -3.50% | +27.92% | +101.00% | +376.24% | +9582.44% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$8.21M
10 txns
Net flow
−$8.21M
Aftermarket
LiveLast trade
$452.53
1 sh
Bid
$432.11
23 sh
Ask
$471.04
8 sh
Spread
$38.930
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q4 Dec 2025 | $3.23B | $1.19B | $4.65 |
| Q3 Sep 2025 | $3.08B | $1.08B | $4.20 |
| Q2 Jun 2025 | $2.96B | $1.03B | $3.99 |
| Q1 Mar 2025 | $2.77B | $646.3M | $2.49 |
| Q4 Dec 2024 | $2.91B | $913M | $3.50 |
| Q3 Sep 2024 | $2.77B | $1.05B | $4.01 |
Sector & industry today
LiveSectors
- Communication Services+1.27%
- Consumer Defensive+0.71%
- Energy+0.36%
- Financial Services-0.01%
- Real Estate-0.10%
- Healthcare-0.64%
- Technology-0.75%
- Consumer Cyclical-1.09%
- Basic Materials-1.81%
- Utilities-2.31%
- Industrials-3.22%
Top industries (issuer's industry highlighted)
- Biotechnology+2.32%
- Engineering & Construction-5.41%
- Independent Power Producers-4.65%
- Agricultural - Machinery-4.52%
- Construction-4.41%
- Auto - Recreational Vehicles-4.03%
- Department Stores-3.97%
- Industrial - Machinery-3.93%
- Construction Materials-3.39%
- Renewable Utilities-3.37%
- Auto - Parts-3.34%
- Rental & Leasing Services-3.23%
Analyst view
DB · price_targets + analyst_gradesConsensus target
$552.27
+26.75% upside
Low
$437.00
Median
$558.00
High
$612.00
Recent actions
0 ↑0 ↓8 hold
- Apr 01, 2026
- Mar 01, 2026
- Feb 01, 2026
- Jan 01, 2026
- Dec 01, 2025
News
DB · news_items- Vertex Pharmaceuticals (VRTX) Declines More Than Market: Some Information for Investorszacks.com·Jun 10, 2026
- Vertex Pharmaceuticals Incorporated (VRTX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcriptseekingalpha.com·Jun 10, 2026
- Vertex (VRTX) Up 0.2% Since Last Earnings Report: Can It Continue?zacks.com·Jun 03, 2026
- Vertex (VRTX) Reports Q1 Earnings: What Key Metrics Have to Sayzacks.com·May 04, 2026
- Vertex Pharmaceuticals (VRTX) Q1 Earnings and Revenues Beat Estimateszacks.com·May 04, 2026
Peers
Total assets
$26.14B
Total debt
$3.88B
Cash & equiv
$5.09B
Operating CF
$3.63B
Free cash flow
$3.19B
Buybacks
-$2.02B
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
Bhatia Sangeeta N. director | Sell | 318 | $134.75K | May 04, 2026 |
Liu Joy officer: EVP and Chief Legal Officer | Sell | 1,104 | $469.22K | May 01, 2026 |
Liu Joy officer: EVP and Chief Legal Officer | Sell | 978 | $439.29K | Apr 01, 2026 |
Bozic Carmen officer: EVP and CMO | Sell | 2,329 | $1.05M | Mar 27, 2026 |
Bozic Carmen officer: EVP and CMO | Sell | 2,329 | $1.12M | Mar 13, 2026 |
McKechnie Duncan officer: EVP, Chief Commercial Officer | Sell | 2,633 | $1.31M | Mar 11, 2026 |
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2025 | $12.07B | $4.76B | $3.95B | $15.32 | +32.74% |
| FY 2024 | $11.02B | -$232.9M | -$535.6M | $-2.08 | -4.86% |
| FY 2023 | $9.87B | $3.83B | $3.62B | $13.89 | +36.68% |
| FY 2022 | $8.93B | $4.31B | $3.32B | $12.82 | +37.20% |
| FY 2021 | $7.57B | $2.78B | $2.34B | $9.01 | +30.92% |